Anti-Trastuzumab ELISA Kit (AY286018)

Aperçu

Numéro de catalogue	AY286018
Description	Anti-Trastuzumab ELISA Kit (AY286018) — Quantitative sandwich ELISA for Anti-Trastuzumab. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Plage	156.25 - 10, 000 ng/mL
Numéro d'accès	P04626
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	80-120%
Expédition	2-8 ℃
Stabilité et stockage	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Spécifications	Trastuzumab
Noms alternatifs	timigutuzumab, 4D5-8, 4D5V8, Herceptin, rhuMab HER2, 180288-69-1
Contexte	Receptor tyrosine-protein kinase erbB-2 (Trastuzumab) is a ~137 kDa protein. Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane.
Note	For Research Use Only.